RxDoctor Payments Data

Devron Osborne, DO

Internal Medicine · Fort Smith, ARNPI 1851742712

Payments from drug & device makers

$545in general payments, 2019–2025

Across 16 payments — averaging $34.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$103
  • E.r. Squibb & Sons, L.L.C.$95
  • Shire North American Group Inc$90
  • Johnson & Johnson$86
  • Pfizer$74
  • AbbVie$43
  • plus $54 from 2 others

What the payments were for

  • Food & beverage$545100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$545 in reported general payments places this provider in the 65th percentile of 614 internal medicine providers in Arkansas.

See all internal medicine providers in Arkansas

Medicare billing

Part B allowed, 2024
$81,391
Medicare patients
347
Services billed
910

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban35$20,260
EntrestoSacubitril/Valsartan20$13,468
BrilintaTicagrelor15$6,802
Metoprolol Succinate59$339
Albuterol Sulfate HfaAlbuterol Sulfate12$324
ClopidogrelClopidogrel Bisulfate29$289
Cefdinir35$253
Pantoprazole Sodium27$243
Azithromycin20$159
Furosemide53$150
Atorvastatin Calcium36$139
Nitroglycerin12$114
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen17$101
Ondansetron OdtOndansetron12$101
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst13$94

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$74$20,26035 claims
NovartisEntresto$20$13,46820 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 614 internal medicine providers in Arkansas.

Other internal medicine in Fort Smith

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →